
Home » Prescription Drugs 3 » BETAGLIM Amaryl
Glimepiride is an anti-diabetic drug (sulfonylurea-type) used along with a proper diet and exercise program to control high blood sugar. It is used in patients with type 2 diabetes (non-insulin-dependent diabetes). It works by stimulating the release of your body's natural insulin. Effectively controlling high blood sugar helps prevent heart disease strokes kidney disease blindness and circulation problems as well as sexual function problems (impotence).How to use Glimepiride OralTake this medication by mouth usually once daily with breakfast or the first main meal of the day. The dosage is based on your medical condition and response to therapy.Use this medication regularly in order to get the most benefit from it. To help you remember use it at the same time each day. Monitor blood glucose levels on a regular basis and share the results with your doctor.
Buy BETAGLIM Amaryl and other Prescription Drugs 3 products online
at Medstore.
Buy Online at Medstore - Click Here!

About BETAGLIM Amaryl:
Product Type: Prescription Drugs 3
BETAGLIM ( Amaryl Generic Glimepiride )
BETAGLIM (Amaryl Generic Glimepiride)
Amaryl Generic Glimepiride
3mg Tabs 30 ( 3 x 10) 4mg Tabs
Amaryl Generic Glimepiride BETAGLIM

View more
Prescription Drugs 3
Previous Product Next Product
Without A Prescription:
Education on antibiotic prescribing in Quebec worked. Guidelines for Quebec doctors on proper antibiotic use led to a decline in these prescriptions in the province, while prescribing rose in other provinces, a new study suggests.
The guidelines were published and disseminated to Quebec doctors and pharmacists in January 2005 due to worries about the overuse of antibiotics and partly as a response to an outbreak of Clostridium difficile infections.
Antibiotic consumption per capita was already 23.3 per cent higher in Canada generally than in Quebec in 2004, the study showed.
But in the year that followed publication of the guidelines, the number of outpatient antibiotic prescriptions in Quebec decreased 4.2 per cent, the study said, while increasing 6.5 per cent in other Canadian provinces. The trend persisted three years later.


|